CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
XOS
Xos, Inc.
There isn't enough reported data to score XOS yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
XOS Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Unavailable |
XOS's revenue, profitability and cash flow are currently weak. There isn't enough data to rate its balance sheet.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
XOS PE Valuation
XOS has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
XOS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect XOS's losses to shrink, with revenue growing.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over XOS on earnings quality, reporting a profit while its opponent remains loss making.
XOS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.26 | +$2.03 |
| Q2 2026 | -$1.52 | +$4.31 |
| Q1 2026 | -$1.88 | +$4.27 |
| Q4 2025 | -$2.71 | +$3.98 |
| Q3 2025 | -$4.29 | +$2.37 |
| Q2 2025 | -$5.83 | +$1.91 |
| Q1 2025 | -$6.15 | +$4.56 |
| Q4 2024 | -$6.69 | +$6.42 |
XOS is still losing money, but far less than before: $2.26 per share over the past year, against $15.30 at its worst in mid-2023.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over XOS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over XOS on profitability, with a higher operating margin.
XOS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.5M | -66% |
| Q2 2026 | $4.7M | -74% |
| Q1 2026 | $11.2M | +91% |
| Q4 2025 | $5.2M | -55% |
| Q3 2025 | $16.5M | +4.5% |
| Q2 2025 | $18.4M | +18% |
| Q1 2025 | $5.9M | -55% |
| Q4 2024 | $11.5M | -38% |
XOS's revenue has slid since its 2025 peak: $6M last quarter, down 66% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -135% | -92 points |
| Q2 2026 | -168% | -129 points |
| Q1 2026 | -42% | +116 points |
| Q4 2025 | -187% | -60 points |
| Q3 2025 | -42% | +19 points |
| Q2 2025 | -39% | +35 points |
| Q1 2025 | -158% | -80 points |
| Q4 2024 | -127% | -63 points |
XOS's operating margin was −135% last quarter, down 92 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over XOS on cash generation, producing positive trailing cash flow while its opponent burns cash.
XOS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2.7M | -188% |
| Q2 2026 | -$2.7M | -158% |
| Q1 2026 | -$1.6M | +$3.1M |
| Q4 2025 | $2.4M | -27% |
| Q3 2025 | $3.1M | +$14.7M |
| Q2 2025 | $4.6M | +$30.8M |
| Q1 2025 | -$4.8M | +$9.9M |
| Q4 2024 | $3.3M | +$4.2M |
XOS has burned cash in most quarters: −$5M over the past year, against $6M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over XOS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
XOS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +16% | +2M shares |
| 1 year | +76% | +6.3M shares |
| 3 years | +158% | +8.9M shares |
XOS has 15M diluted shares, up 76% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $3,000 |
| Q2 2020 | — |
| Q1 2020 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
XOS Net Leverage
XOS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
XOS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.3 | Neutral |
| Stochastic | 20.3 | Neutral |
XOS's weekly RSI is 45 (neutral) and its Stochastic is 20 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
XOS PE vs Industrials Sector
| Metric | XOS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
XOS has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over XOS on trend strength, trading above more of its moving averages.
XOS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.76 | 17% below |
| 20 week MA | $2.68 | 15% below |
| 50 week MA | $2.43 | 5.8% below |
| 100 week MA | $2.83 | 19% below |
| 200 week MA | $6.50 | 65% below |
XOS is in a downtrend: it's below all five of its weekly moving averages, and 65% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
XOS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $299.7 | $302.4 | +0.9% |
| 2021 | $302.4 | $91.5 | -70% |
| 2022 | $91.5 | $16.5 | -82% |
| 2023 | $16.5 | $7.98 | -52% |
| 2024 | $7.98 | $3.16 | -60% |
| 2025 | $3.16 | $2.02 | -36% |
| 2026 YTD | $2.02 | $2.29 | +13% |
XOS has the edge over CAT on returns for 2026, with the stronger performance.